GAFFI Priority Fungal infections
GAFFI has identified five fungal infections as its highest priorities. For more detailed information, please download the fact sheets below.
For more information on the “Hidden Crisis” of fungal diseases view here.
GAFFI’s brochure (September 2017) summarised the burden of fungal diseases and its achievements over 4 years.
Cryptococcal meningitis Fact Sheet
Cryptococcal meningitis in AIDS (100% mortality undiagnosed and untreated, >75% survival with best treatment)
Pneumocystis pneumonia Fact Sheet
Pneumocystis pneumonia in AIDS, cancer and other groups (100% mortality undiagnosed and untreated, >80% survival with best treatment)
Disseminated histoplasmosis Fact Sheet
Disseminated histoplasmosis especially in AIDS (most common in the Americas) (100% mortality undiagnosed and untreated, >90% survival with best treatment)
Chronic pulmonary aspergillosis Fact Sheet
Chronic pulmonary aspergillosis following TB and other pulmonary diseases (slowly progressive, destructive lung infection with high morbidity, ~15% annual mortality, over 60% response with oral therapy)
Fungal keratitis Fact Sheet
Fungal keratitis following eye injury (if untreated usually leads to blindness, 75% visual recovery with antifungal treatment of mild/moderate infection)
Chromoblastomycosis Fact Sheet
Chromobastomycosis (chromo) a neglected tropical skin disease of poor agricultural workers and curable in the early stages